Peter Ferdinandy

• Vice-rector for science and innovations of the Semmelweis University, Budapest, Hungary
• Founder of Pharmahungary Group (www.pharmahungary.com)
• Editor-in-chief of the British Journal of Pharmacology

Expert in cardiovascular medicine and pharmacology. His work focuses on cardiovascular research, drug development, and translational medicine, combining clinical expertise with advanced scientific and management skills. He is recognized for his contributions to understanding cardiovascular diseases and improving therapeutic strategies. His published work has an important impact on cardiovascular scientific society, being highly cited (h-index 83). He was awarded as Highly Cited Researcher in 2014, 2017, 2020, 2021, and 2022 for his contribution in RNA therapeutics, AI-driven drug development.